Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration 21 CFR Parts 520 and 558
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Final rule.
 SUMMARY: The  Food  and  Drug  Administration  (FDA) is amending the animal drug regulations to reflect a change of sponsor  for an approved new animal drug application (NADA) from Hess & Clark, Inc., to Phoenix Scientific, Inc.
 DATES: This  rule is effective October 12, 2004.
 FOR FURTHER INFORMATION  CONTACT: David  R. Newkirk, Center   for   Veterinary   Medicine   (HFV-100),   Food   and   Drug Administration,     7500     Standish    Pl.,    Rockville,    MD    20855, 301-827-6967,                    e-mail: 
                        *david.newkirk@fda.gov*.


SUPPLEMENTARY INFORMATION: Hess  & Clark, Inc., 944 Nandino Blvd.,  Lexington,  KY  40511,  has informed FDA  that  it  has  transferred  ownership of , and all rights and interest  in, the following three approved NADAs,  to  Phoenix  Scientific, Inc., 3915 South 48th Street Ter., St. Joseph, MO 64503: NADA Number
Trade Name6-391
S.Q. (sulfaquinoxaline) 40% Medicated Feed6-677
S.Q. (sulfaquinoxaline) 20% Solution7-087
Sulfaquinoxaline Solubilized
 Accordingly,  the agency is amending the regulations in 21 CFR 520.2325a and 558.586 to reflect the transfer of ownership and a current format. This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because  it  is a rule of “particular applicability.” Therefore, it is not subject  to the congressional review requirements in 5 U.S.C. 801-808. List of Subjects 21 CFR Part 520 Animal drugs 21 CFR Part 558 Animal drugs
Animal feeds
 Therefore,  under  the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food  and Drugs and redelegated to the Center for Veterinary  Medicine,  21 CFR parts 520 and  558 are amended as follows: PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS
 1. The authority citation for 21 CFR part 520 continues to read as follows: Authority:
                        21 U.S.C. 360b. § 520.2325a
 2.Section  520.2325a  is  amended  in paragraph (a)(1) by removing “050749”      and      by      adding      in     its     place “059130”. PART    558—NEW   ANIMAL   DRUGS   FOR   USE   IN   ANIMAL FEEDS
 3. The authority citation for 21 CFR part 558 continues to read as follows: Authority:
                        21 U.S.C. 360b, 371. 4.Section 558.586  is  amended by revising the section heading; by removing paragraphs (c) and (d); by redesignating paragraphs (e) and (f) as paragraphs (c) and (d); and by revising paragraph (a) and adding paragraph (b) to read as follows: § 558.586
 (a) 
                        *Specifications*. Type A medicated  articles  containing 40 percent sulfaquinoxaline. (b) 
                        *Approvals*. See No. 059130 in § 510.600(c) of this chapter. 
 Dated: September 27, 2004. Steven D. Vaughn, Director,   Office   of  New  Animal  Drug  Evaluation,  Center  for Veterinary Medicine.


[FR Doc. 04-22760 Filed 10-8-04; 8:45 am] BILLING CODE 4160-01-S